Matthey-Gié Marie-Laure, Gié Olivier, Deretti Sona, Demartines Nicolas, Matter Maurice
Department of Visceral Surgery, Centre Hospitalier Universitaire Vaudois, CHUV, University Hospital of Lausanne, Lausanne, Switzerland.
Ann Surg Oncol. 2016 May;23(5):1716-20. doi: 10.1245/s10434-015-5025-y. Epub 2015 Dec 29.
Many attempts to prevent lymphatic complications following therapeutic lymph node dissection (TLND) have included modifications in surgical techniques through the use of ultrasonic scalpels (USS) or lymphostatic agents. Previous randomized studies that enrolled heterogeneous groups of patients attempted to confirm the efficacy of such techniques. The aim of the present study was to evaluate the efficacy of the USS following TLND.
Between 2009 and 2013, patients undergoing inguinal or axillary TLND or completion lymph node dissection after positive sentinel lymph node biopsy for melanoma, squamous cell carcinoma or sarcoma were randomized into two surgical dissection technique groups. In the USS dissection arm, surgery was conducted using a USS. These were compared with a control group whereby ligation and monopolar electrocautery was utilized. For axillary dissection, a standardized level III lymphadenectomy was performed. A complete inguinal lymphadenectomy including Cloquet's node was performed, and at the end of the procedure a Redon suction drain was routinely placed in the axilla and groin. The primary endpoint was to compare the time to drain removal in both groups, while the secondary endpoint was to evaluate the rate of complications (infection, fistula, lymphocele formation, wound dehiscence, lymphedema) between the two groups.
A total of 80 patients were enrolled in this trial; 40 patients were randomly assigned to both the USS group and the control (C) group. No significant differences were observed in terms of duration of drainage (USS: 31 ± 20 vs. C: 32 ± 18; p = 0.83); however, a significantly increased rate of lymphedema (defined as an increased circumference of the operated limb of more than 10 %) was identified in the USS group (USS: 50 % vs. C: 27.5 %; p = 0.04). No other significant differences were recorded for postoperative complications, including surgical site infection (USS: 5 % vs. C: 7.5 %; p = 0.68), lymphatic fistula (USS: 5 % vs. C: 2.5 %; p = 0.62), lymphocele (USS: 32.5 % vs. C: 22.5 %; p = 0.33), and hematoma (USS: 5 % vs. C: 2.5 %; p = 0.62).
The use of USS failed to offer any significant reduction in length of drain usage and operative complication, but it seems to increase the rate of lymphedema formation.
为预防治疗性淋巴结清扫术(TLND)后的淋巴并发症,人们进行了多种尝试,包括通过使用超声刀(USS)或淋巴压迫剂来改进手术技术。之前纳入不同患者群体的随机研究试图证实这些技术的疗效。本研究的目的是评估TLND后超声刀的疗效。
2009年至2013年期间,因黑色素瘤、鳞状细胞癌或肉瘤而接受腹股沟或腋窝TLND或前哨淋巴结活检阳性后进行根治性淋巴结清扫的患者被随机分为两个手术解剖技术组。在超声刀解剖组中,使用超声刀进行手术。将这些患者与使用结扎和单极电灼的对照组进行比较。对于腋窝清扫,进行标准化的Ⅲ级淋巴结清扫术。进行包括闭孔淋巴结在内的完整腹股沟淋巴结清扫术,手术结束时,常规在腋窝和腹股沟放置雷顿吸引引流管。主要终点是比较两组的引流管拔除时间,次要终点是评估两组之间的并发症发生率(感染、瘘管、淋巴囊肿形成、伤口裂开、淋巴水肿)。
本试验共纳入80例患者;40例患者被随机分配到超声刀组和对照组。在引流持续时间方面未观察到显著差异(超声刀组:31±20天 vs. 对照组:32±18天;p = 0.83);然而,超声刀组的淋巴水肿发生率显著增加(定义为手术肢体周长增加超过10%)(超声刀组:50% vs. 对照组:27.5%;p = 0.04)。术后并发症方面未记录到其他显著差异,包括手术部位感染(超声刀组:5% vs. 对照组:7.5%;p = 0.68)、淋巴瘘(超声刀组:5% vs. 对照组:2.5%;p = 0.62)、淋巴囊肿(超声刀组:32.5% vs. 对照组:22.5%;p = 0.33)和血肿(超声刀组:5% vs. 对照组:2.5%;p = 0.62)。
使用超声刀未能显著缩短引流管使用时间和降低手术并发症,但似乎会增加淋巴水肿的发生率。